Company Valuation: Dexin Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 653.6 1,002 535 691.2 693.2 1,428
Change - 53.29% -46.6% 29.21% 0.29% 106.02%
Enterprise Value (EV) 1 618 890.1 444.1 652.9 684.9 1,274
Change - 44.02% -50.11% 47.04% 4.9% 86.07%
P/E 30.8x 16.6x -10.3x -7.29x -16.4x -30.3x
PBR 1.76x 2.33x 1.23x 1.99x 2.28x 4.13x
PEG - 0x 0x -0.1x 0.3x 11.64x
Capitalization / Revenue 0.8x 0.81x 0.97x 1.78x 1.53x 2.98x
EV / Revenue 0.76x 0.72x 0.8x 1.69x 1.51x 2.66x
EV / EBITDA 19.5x 10.7x -8.81x -6.68x -13.5x -141x
EV / EBIT 33.9x 12.7x -6.85x -5.76x -10.1x -49.3x
EV / FCF -9.56x 14x -25.5x -10.4x -10.7x 16.1x
FCF Yield -10.5% 7.14% -3.92% -9.65% -9.33% 6.22%
Dividend per Share 2 0.1586 0.7692 - - - -
Rate of return 0.86% 2.74% - - - -
EPS 2 0.6007 1.692 -1.3 -2.365 -1.052 -1.025
Distribution rate 26.4% 45.5% - - - -
Net sales 1 813.5 1,231 552 387.4 454 479.3
EBITDA 1 31.65 83.11 -50.38 -97.8 -50.78 -9.058
EBIT 1 18.22 69.84 -64.85 -113.4 -67.54 -25.87
Net income 1 21.38 60.16 -50.76 -94.78 -42.16 -43.89
Net Debt 1 -35.52 -111.7 -90.9 -38.3 -8.334 -153.8
Reference price 2 18.48 28.08 13.35 17.25 17.30 31.00
Nbr of stocks (in thousands) 35,357 35,682 40,072 40,072 40,072 46,071
Announcement Date 21/04/21 31/03/22 30/03/23 15/03/24 17/03/25 12/03/26
1TWD in Million2TWD
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 26.41M
20.35x1.71x13.5x0.51% 314B
6.46x3.48x4.32x-.--% 206B
17.94x7.71x13.81x0.43% 161B
16.3x6.79x12.11x0.16% 148B
21.61x2.01x10.3x0.94% 80.09B
142.17x8.82x38.87x-.--% 46.19B
28.82x5.18x15.69x0.94% 43.93B
12.31x0.37x10.5x5.76% 39.2B
30.93x5.44x18.54x1.36% 38.89B
Average 32.99x 4.61x 15.29x 1.12% 107.69B
Weighted average by Cap. 22.53x 4.20x 12.61x 0.6%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Dexin Corporation

Historical PBR trend

Valuation ratios - PBR - Dexin Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Dexin Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Dexin Corporation

  1. Stock Market
  2. Stocks
  3. 3349 Stock
  4. Valuation Dexin Corporation